TY - JOUR
T1 - Modular and Nondisturbing Chimeric Adaptor Protein for Surface Chemistry of Small Extracellular Vesicles
AU - Jang, Juhee
AU - Shin, Jiwon
AU - Ahn, Yongdeok
AU - Kim, Kiwook
AU - Cho, Juhyeong
AU - Lee, Wonhee John
AU - Nam, Chaerin
AU - Baek, Moon Chang
AU - Seo, Daeha
AU - Yea, Kyungmoo
N1 - Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025/4/8
Y1 - 2025/4/8
N2 - Current chemical strategies for modifying the surface of extracellular vesicles (sEVs) often struggle to balance efficient functionalization with preserving structural integrity. Here, we present a modular approach for the surface modification of sEVs using a chimeric adaptor protein (CAP). The CAP was designed with three key features: a SNAP-tag for stable and modular binding, long and rigid linker to enhance spatial accessibility and conjugation efficiency, and the N-terminal sorting domain derived from syntenin to improve CAP expression on the sEV. We established a postsynthetic method to introduce diverse functional molecules onto sEVs, creating a versatile system termed “sEV-X” (where X represents an organic molecule, protein, or nanoparticle). Quantitative analyses at the single-molecule level revealed a linear relationship between CAP expression and the number of conjugated functional molecules, underscoring the importance of steric hindrance mitigation in sEV surface engineering. Moreover, antibody-conjugated sEVs as drug carriers, demonstrated significant tumor-specific delivery and therapeutic efficacy in a tumor-bearing mouse model, underscoring the potential of CAP-expressing sEVs as a customizable therapeutic vesicle. Overall, the CAP technology may serve as a universal platform for advancing the development of sEV-based therapeutics.
AB - Current chemical strategies for modifying the surface of extracellular vesicles (sEVs) often struggle to balance efficient functionalization with preserving structural integrity. Here, we present a modular approach for the surface modification of sEVs using a chimeric adaptor protein (CAP). The CAP was designed with three key features: a SNAP-tag for stable and modular binding, long and rigid linker to enhance spatial accessibility and conjugation efficiency, and the N-terminal sorting domain derived from syntenin to improve CAP expression on the sEV. We established a postsynthetic method to introduce diverse functional molecules onto sEVs, creating a versatile system termed “sEV-X” (where X represents an organic molecule, protein, or nanoparticle). Quantitative analyses at the single-molecule level revealed a linear relationship between CAP expression and the number of conjugated functional molecules, underscoring the importance of steric hindrance mitigation in sEV surface engineering. Moreover, antibody-conjugated sEVs as drug carriers, demonstrated significant tumor-specific delivery and therapeutic efficacy in a tumor-bearing mouse model, underscoring the potential of CAP-expressing sEVs as a customizable therapeutic vesicle. Overall, the CAP technology may serve as a universal platform for advancing the development of sEV-based therapeutics.
KW - EV surface chemistry
KW - drug delivery
KW - protein engineering
KW - single-molecule analysis
KW - small extracellular vesicle (sEV)
UR - https://www.scopus.com/pages/publications/105002495475
U2 - 10.1021/acsnano.4c15441
DO - 10.1021/acsnano.4c15441
M3 - Article
C2 - 40119814
AN - SCOPUS:105002495475
SN - 1936-0851
VL - 19
SP - 12839
EP - 12852
JO - ACS Nano
JF - ACS Nano
IS - 13
ER -